Preliminary review by Los Angeles County election officials finds errors in the federal list, raising the stakes for voter roll integrity ahead of November.

A new University of Mississippi and Cornell review finds precision weed tools can replace chemicals and labor, yet adoption comes with serious financial and operational hurdles.

A 10,000-person study finds standard antidepressants often fail these patients, but melatonin and morning sunlight may hit the real root cause.

AI meeting notetaker lands $320M to chase enterprise deals and global expansion.

If the claim holds up, personalized phage therapy could become a new frontline weapon against antibiotic resistance - but proof is far from final.

Security researchers enumerated thousands of Meta Muse share links, exposing personal and business data despite Zuckerberg's privacy promise.

The UK's top spy says AI is making biological attacks more accessible; Johns Hopkins' Tom Inglesby explains why governments are scrambling and what safeguards could stop it.

Revolut, Halifax, and Emma went dark Tuesday as Google's London cloud region failed. Here's what it means for fintech's reliance on Big Tech infrastructure.

A final call from Beijing puts high-net-worth individuals on notice: declare offshore trust gains by October 22 or face penalties, with ripple effects for Hong Kong's wealth hub.

Google's premium ChromeOS-Android hybrid starts at $899, but the first major review says the software can't match the hardware. A risky debut against the MacBook Air and Surface Laptop.

The Tel Aviv startup's code execution model formally verifies optimizations, turning AI into an agent for the hardware itself.

MIT team traces APOE4's damage to lipid droplets, opening a new drug target beyond amyloid and tau.